Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Financing Activities (2022 - 2025)

Gossamer Bio's Cash from Financing Activities history spans 4 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities changed N/A year-over-year to $4.0 million; the TTM value through Dec 2025 reached $6.4 million, up 155.93%, while the annual FY2025 figure was $6.4 million, 155.93% up from the prior year.
  • Cash from Financing Activities reached $4.0 million in Q4 2025 per GOSS's latest filing, up from $1.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $198.5 million in Q3 2023 to a low of -$9.2 million in Q2 2024.
  • Average Cash from Financing Activities over 4 years is $20.1 million, with a median of $94000.0 recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: tumbled 13928.57% in 2023, then skyrocketed 566.19% in 2025.
  • A 4-year view of Cash from Financing Activities shows it stood at -$2.9 million in 2022, then dropped by 1.04% to -$2.9 million in 2023, then skyrocketed by 109.68% to $281000.0 in 2024, then soared by 1307.47% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Cash from Financing Activities are $4.0 million (Q4 2025), $1.9 million (Q3 2025), and $94000.0 (Q2 2025).